Streetbeat News

Products Services

LCID

NIO

RIVN

TSLA

XPEV

Tesla Inc (NASDAQ:TSLA) reported disappointing Q2 results, missing earnings expectations and causing an 8% drop in premarket trading. This decline also affected shares of Rivian Automotive Inc (NASDAQ:RIVN), Lucid Group Inc (NASDAQ:LCID), Nio Inc (NYSE:NIO), and XPeng Inc (NYSE:XPEV). Tesla's automotive revenue dropped 7% YoY, and adjusted income plummeted 43% YoY. Despite remaining the top EV seller in the U.S., Tesla is losing market share to rivals. CEO Elon Musk announced plans for an affordable EV by 2025 and delayed the robotaxi details release to October 10th.

Portfolio Pulse from Upwallstreet

July 24, 2024 | 3:17 pm

XOM

ExxonMobil announced that its Joliet, Illinois refinery has sufficient power to begin restart operations.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 3:09 pm

BIIB

SAGE

Sage Therapeutics Inc. (NASDAQ:SAGE) and Biogen Inc. (NASDAQ:BIIB) announced disappointing results from the Phase 2 KINETIC 2 study of SAGE-324 for essential tremor, leading to the discontinuation of its development. SAGE stock fell 16.4%, while BIIB stock saw a slight increase of 0.19%.

Portfolio Pulse from Vandana Singh

July 24, 2024 | 3:05 pm

VSH

Vishay Intertechnology has introduced AEC-Q200 qualified thin film chip resistors with high-frequency performance up to 70 GHz. These resistors are available in a compact 02016 case size and a range of 10 Ω to 500 Ω, targeting automotive, space, avionics, telecom, and military applications.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 3:01 pm

KEYS

Keysight Technologies has completed the first Car Connectivity Consortium Digital Key Applet certification for NXP Semiconductors. This move strengthens the security of next-generation vehicles and expands Keysight's automotive security evaluation offerings.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 3:00 pm

ACTU

Actuate Therapeutics, Inc (NASDAQ:ACTU) is set to IPO on July 25 on the NASDAQ exchange with shares priced between $8.00 and $10.00. The insider lock-up period will end on January 21, 2025. Actuate Therapeutics is a clinical stage biopharmaceutical company focusing on therapies for difficult-to-treat cancers.

Portfolio Pulse from Benzinga Insights

July 24, 2024 | 3:00 pm

COSM

Cosmos Health's subsidiary, Cana Laboratories, has completed Phase I of its manufacturing upgrades. The company is now positioned to generate over $10 million in recurring annual gross profit by the end of 2025.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 2:58 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for July 24th, 2024, provides a detailed analysis of SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. The memo outlines key price levels and potential movements for each asset, advising traders to monitor these stocks closely for breakouts or reversals. Significant economic data releases today are expected to increase market volatility.

Portfolio Pulse from RIPS

July 24, 2024 | 2:54 pm

NVDA

Nvidia has developed a new chip specifically for the Chinese market that features a special server design to comply with U.S. export regulations. This move aims to maintain Nvidia's presence in China despite the tightening of U.S. rules on technology exports.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 2:50 pm

TSLA

Elon Musk stated that a Trump presidency and the potential repeal of the Inflation Reduction Act (IRA) would be devastating for Tesla's competitors but might benefit Tesla in the long term. Musk also mentioned postponing plans for a gigafactory in Mexico due to potential tariffs under a Trump administration.

Portfolio Pulse from Anan Ashraf

July 24, 2024 | 2:45 pm